AUS
NZ
UK
CA
USA
IND
Highlights
- Safe Supply partners with Greenlane to distribute Toxi Shield iodine tablets globally.
- Greenlane to offer premium health and safety products amid growing nuclear safety concerns.
- Exclusive distribution deal to expand Safety Strips' market reach, focusing on health and harm reduction.
Safe Supply Streaming Co. Ltd. (CSE:SPLY) (FSE: QM4) (OTCQB: SSPLF) is excited to announce a strategic collaboration between its portfolio company, Safety Strips Tech Corp., and Greenlane Holdings, Inc. (NASDAQ:GNLN), a leading global seller of premium cannabis accessories and specialty health products. Greenlane has initiated the distribution of Safety Strips’ Toxi Shield iodine tablets, a health and safety product designed to protect the thyroid gland during radiation emergencies, such as nuclear events.
Product Overview and Strategic Relevance
The Toxi Shield iodine tablets are manufactured in a Good Manufacturing Practice (GMP)-certified facility in the USA and are endorsed by health authorities for reducing the risk of exposure to radioactive iodine in the event of nuclear accidents. As global geopolitical tensions rise and nuclear energy is increasingly back in focus, the demand for products like Toxi Shield that provide protection against radiation exposure is expected to grow.
The Toxi Shield iodine tablets are an important addition to Greenlane's portfolio, expanding its product diversification strategy into health, safety, and wellness solutions. The introduction of these tablets aligns with the growing need for preparedness in light of recent global events and directives from various governments encouraging citizens to stockpile potassium iodide tablets for emergency situations.
Greenlane's Strategic Move
Barbara Sher, CEO of Greenlane Holdings, commented on the new product addition:
"The addition of Toxi Shield iodine tablets reflects Greenlane's commitment to diversifying our product offerings to include health, safety, and wellness solutions. With the rising concerns around nuclear safety and emergency preparedness, we see significant growth potential for this premium product. Our robust distribution platform positions us to maximize the reach of this critical health solution."
This partnership with Safety Strips allows Greenlane to leverage its extensive distribution network, ensuring that Toxi Shield iodine tablets reach a broad consumer base. The product’s appeal is particularly high in markets where there is heightened awareness around nuclear safety and the importance of radiation protection.
Safety Strips' Expansion into the U.S. Market
Geoff Benic, CEO of Safety Strips, emphasized the significance of the partnership:
"The partnership with Greenlane provides an efficient route into the massive U.S. market, allowing us to leverage their extensive distribution network and established relationships."
Safety Strips will benefit from Greenlane’s large-scale distribution capacity, which will support the company’s entry into new markets and enhance its ability to meet growing demand for health and safety products. This collaboration is expected to drive significant growth and expand the global market access for Safety Strips’ portfolio.
Key Highlights of the Partnership
- Premium Quality Assurance: Toxi Shield iodine tablets are manufactured in GMP-certified facilities in the USA to the highest industry standards.
- Global Distribution: An exclusive distribution agreement, signed on November 7, 2024, enables Greenlane to distribute Toxi Shield iodine tablets globally.
- Timely Market Relevance: The product addresses recent directives from Swedish and Norwegian governments encouraging citizens to maintain a supply of potassium iodide tablets in response to rising concerns about nuclear safety.
